GENSIGHT BIOLOGICS S.A. (EPA:SIGHT) | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Headlines Articles Press releases GENSIGHT BIOLOGICS S.A.

Home
Companies
GENSIGHT BIOLOGICS S.A.

BRIEF

published on 11/01/2024 at 18:23, 1 day 18 hours ago

GenSight Biologics obtient un financement de 2,8 millions d'euros

Financement Thérapie Génique Mandats GenSight Biologics Maladies De La Rétine
BRIEF

published on 11/01/2024 at 18:23, 1 day 18 hours ago

GenSight Biologics Secures €2.8 Million Financing

Warrants Financing Gene Therapy GenSight Biologics Retinal Diseases
PRESS RELEASE

published on 11/01/2024 at 18:18, 1 day 18 hours ago

Informations privilégiées / Autres communiqués
GenSight Biologics annonce un financement de 2,8 millions d’euros auprès d’investisseurs existants pour soutenir le développement de thérapies géniques innovantes

Développement Financement Investisseurs GenSight Biologics Thérapies Géniques
PRESS RELEASE

published on 11/01/2024 at 18:18, 1 day 18 hours ago

Inside Information / Other news releases
GenSight Biologics announces a €2.8 million financing through a Reserved Offering. Funding to extend cash runway for developing gene therapies. Details on investor support and future plans

Investors Financing GenSight Biologics Gene Therapies Reserved Offering
BRIEF

published on 10/24/2024 at 21:13, 9 days 15 hours ago

GenSight Biologics dévoile sa situation de trésorerie et avance sur le LUMEVOQ®

Financement Trésorerie LUMEVOQ® Accès Compassionnel ANSM
BRIEF

published on 10/24/2024 at 21:13, 9 days 15 hours ago

GenSight Biologics Discloses Cash Position, Advances on LUMEVOQ®

Treasury Funding LUMEVOQ® ANSM Compassionate Access
PRESS RELEASE

published on 10/24/2024 at 21:08, 9 days 15 hours ago

Inside Information / News release on accounts, results
GenSight Biologics reports €3.4 million cash position as of September 30, 2024, updates on LUMEVOQ® drug product status, and financial discussions for future funding

Cash Position Financial Update GenSight Biologics LUMEVOQ AAC Resumption
PRESS RELEASE

published on 10/24/2024 at 21:08, 9 days 15 hours ago

Informations privilégiées / Communiqué sur comptes, résultats
GenSight Biologics publie sa trésorerie au 30 septembre 2024 et fait un point sur ses activités, notamment le succès des tests du LUMEVOQ et les discussions pour assurer le financement. La trésorerie est de 3,4 millions d'euros

Financement Trésorerie GenSight Biologics LUMEVOQ Tests De Contrôle
BRIEF

published on 10/17/2024 at 07:35, 17 days 5 hours ago

GenSight Biologics présente les données de LUMEVOQ® à l'AAO 2024

Thérapie Génique GenSight Biologics LUMEVOQ® LHON AAO 2024
BRIEF

published on 10/17/2024 at 07:35, 17 days 5 hours ago

GenSight Biologics Presents LUMEVOQ® Data at AAO 2024

Gene Therapy GenSight Biologics LUMEVOQ® LHON AAO 2024

1 2 ... 5

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 16 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 17 hours 46 minutes ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 20 hours 51 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 31 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 19 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE